ZA985210B - Compounds for the inhibition of farnesyl protein transferase - Google Patents

Compounds for the inhibition of farnesyl protein transferase

Info

Publication number
ZA985210B
ZA985210B ZA985210A ZA985210A ZA985210B ZA 985210 B ZA985210 B ZA 985210B ZA 985210 A ZA985210 A ZA 985210A ZA 985210 A ZA985210 A ZA 985210A ZA 985210 B ZA985210 B ZA 985210B
Authority
ZA
South Africa
Prior art keywords
inhibition
compounds
protein transferase
farnesyl protein
farnesyl
Prior art date
Application number
ZA985210A
Other languages
English (en)
Inventor
Ronald J Doll
Joseph M Kelly
Alan K Mallams
F George Njoroge
Stacy W Remiszewski
Arthur G Taveras
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA985210B publication Critical patent/ZA985210B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA985210A 1997-06-17 1998-06-15 Compounds for the inhibition of farnesyl protein transferase ZA985210B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87705797A 1997-06-17 1997-06-17

Publications (1)

Publication Number Publication Date
ZA985210B true ZA985210B (en) 1999-01-07

Family

ID=25369159

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985210A ZA985210B (en) 1997-06-17 1998-06-15 Compounds for the inhibition of farnesyl protein transferase

Country Status (30)

Country Link
EP (2) EP0988300B1 (es)
JP (1) JP2002504148A (es)
KR (1) KR100588799B1 (es)
CN (1) CN1131228C (es)
AR (1) AR016074A1 (es)
AT (1) ATE222905T1 (es)
AU (1) AU753863B2 (es)
BR (1) BR9811470A (es)
CA (1) CA2294347C (es)
CO (1) CO4940455A1 (es)
CZ (1) CZ297450B6 (es)
DE (1) DE69807477T2 (es)
DK (1) DK0988300T3 (es)
ES (1) ES2178224T3 (es)
HK (1) HK1022908A1 (es)
HU (1) HUP0003046A3 (es)
ID (1) ID30349A (es)
IL (2) IL133449A0 (es)
MY (1) MY117925A (es)
NO (1) NO318938B1 (es)
NZ (1) NZ501618A (es)
PE (1) PE83799A1 (es)
PL (1) PL191866B1 (es)
PT (1) PT988300E (es)
RU (1) RU2220139C2 (es)
SK (1) SK283820B6 (es)
TR (2) TR200000114T2 (es)
TW (1) TW544451B (es)
WO (1) WO1998057959A1 (es)
ZA (1) ZA985210B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA003510B1 (ru) 1998-07-06 2003-06-26 Янссен Фармацевтика Н.В. Ингибиторы фарнезилпротеинтрансферазы, применяемые для лечения артропатий
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
PE20020635A1 (es) * 2000-11-29 2002-07-11 Schering Corp Compuestos triciclicos como inhibidores de la farnesil transferasa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
ATE222905T1 (de) 2002-09-15
WO1998057959A1 (en) 1998-12-23
DE69807477D1 (de) 2002-10-02
BR9811470A (pt) 2000-09-19
CO4940455A1 (es) 2000-07-24
CZ447199A3 (cs) 2000-06-14
KR100588799B1 (ko) 2006-06-13
RU2220139C2 (ru) 2003-12-27
SK182499A3 (en) 2000-09-12
HK1022908A1 (en) 2000-08-25
ID30349A (id) 2001-11-22
AR016074A1 (es) 2001-06-20
CZ297450B6 (cs) 2006-12-13
CA2294347A1 (en) 1998-12-23
DE69807477T2 (de) 2003-02-27
TR200003580T2 (tr) 2002-10-21
PL191866B1 (pl) 2006-07-31
ES2178224T3 (es) 2002-12-16
PE83799A1 (es) 1999-10-23
AU8058298A (en) 1999-01-04
TR200000114T2 (tr) 2000-08-21
HUP0003046A2 (hu) 2001-06-28
MY117925A (en) 2004-08-30
SK283820B6 (sk) 2004-02-03
CN1267294A (zh) 2000-09-20
EP1156046A1 (en) 2001-11-21
EP0988300B1 (en) 2002-08-28
PL337481A1 (en) 2000-08-28
PT988300E (pt) 2002-12-31
NZ501618A (en) 2001-10-26
TW544451B (en) 2003-08-01
NO318938B1 (no) 2005-05-30
KR20010013948A (ko) 2001-02-26
NO996236D0 (no) 1999-12-16
AU753863B2 (en) 2002-10-31
DK0988300T3 (da) 2002-11-25
EP0988300A1 (en) 2000-03-29
IL133449A0 (en) 2001-04-30
NO996236L (no) 2000-02-01
JP2002504148A (ja) 2002-02-05
CN1131228C (zh) 2003-12-17
CA2294347C (en) 2008-01-29
IL133449A (en) 2006-12-10
HUP0003046A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
HUP0004148A3 (en) Inhibitors of farnesyl protein transferase
IL124197A (en) Inhibitors of farnesyl protein transferase
IL126833A0 (en) Inhibitors of protein farnesyl transferase
EP0918771A4 (en) THIADIOXOBENZODIAZEPINES FOR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS
EP0696593A3 (en) Farnesyl protein transferase inhibitors
AU5772698A (en) Inhibitors of farnesyl protein transferase
IL123155A0 (en) 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
EP0664789A4 (en) Inhibitors of farnesyl protein transferase.
AP9801257A0 (en) Farnesyl protein transferase inhibiting (imidazol-5-YL) methyl-2-quinoline derivatives
EP1027042A4 (en) FARNESYL PROTEIN TRANSFERASE INHIBITORS
GB9809869D0 (en) Inhibition of protein kinases
IL143409A0 (en) Farnesyl protein transferase inhibitors
ZA985203B (en) Compounds useful for inhibition of farnesyl protein transferase
AU5164898A (en) Thioproline-containing inhibitors of farnesyl protein transferase
AU4020897A (en) 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
ZA986623B (en) Hydantoin derivatives having an inhibitor activity for farnesyl transferase
HUP0202152A2 (en) Tricyclyc farnesyl protein transferase inhibitors
ZA985210B (en) Compounds for the inhibition of farnesyl protein transferase
IL130453A0 (en) Farnesyl transferase inhibitors
ZA985214B (en) Compounds useful for inhibition of farnesyl protein transferase
HUP0002186A3 (en) Compounds useful for inhibition of farnesyl protein transferase
HUP9903221A3 (en) Inhibitors of protein farnesyl transferase
IL141626A0 (en) Farnesyl transferase inhibitors
ZA971621B (en) Inhibitors of farnesyl protein transferase
ZA971254B (en) Farnesyl transferase inhibitors